NIAID Banner Logo Image

HIV Citations List: December, 2015

PubMed Citations

1. Anti-HIV-1 Activity of a Tripodal Receptor That Recognizes Mannose Oligomers. Rivero-Buceta, E., P. Carrero, E. Casanova, E.G. Doyaguez, A. Madrona, E. Quesada, M.J. Perez-Perez, R. Mateos, L. Bravo, L. Mathys, S. Noppen, E. Kiselev, C. Marchand, Y. Pommier, S. Liekens, J. Balzarini, M.J. Camarasa, and A. San-Felix. European Journal of Medicinal Chemistry, 2015. 106: p. 132-143. PMID[26540494].

[PubMed]. HIV_12_2015.


2. Design and Synthesis of Diselenobisbenzamides (Disebas) as Nucleocapsid Protein 7 (Ncp7) Inhibitors with anti-HIV Activity. Sancineto, L., A. Mariotti, L. Bagnoli, F. Marini, J. Desantis, N. Iraci, C. Santi, C. Pannecouque, and O. Tabarrini. Journal of Medicinal Chemistry, 2015. 58(24): p. 9601-9614. PMID[26613134].

[PubMed]. HIV_12_2015.


3. Design, Synthesis, Biological Evaluation and X-ray Structural Studies of HIV-1 Protease Inhibitors Containing Substituted Fused-tetrahydropyranyl Tetrahydrofuran as P2-ligands. Ghosh, A.K., C.D. Martyr, L.A. Kassekert, P.R. Nyalapatla, M. Steffey, J. Agniswamy, Y.F. Wang, I.T. Weber, M. Amano, and H. Mitsuya. Organic & Biomolecular Chemistry, 2015. 13(48): p. 11607-11621. PMID[26462551]. PMCID[PMC4666783].

[PubMed]. HIV_12_2015.


4. Flueggether A and Virosinine A, anti-HIV Alkaloids from Flueggea virosa. Zhang, H., K.K. Zhu, Y.S. Han, C. Luo, M.A. Wainberg, and J.M. Yue. Organic Letters, 2015. 17(24): p. 6274-6277. PMID[26632657].

[PubMed]. HIV_12_2015.


5. Nanogel-conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection. Senanayake, T.H., S. Gorantla, E. Makarov, Y. Lu, G. Warren, and S.V. Vinogradov. Molecular Pharmaceutics, 2015. 12(12): p. 4226-4236. PMID[26565115].

[PubMed]. HIV_12_2015.


6. Nanoparticle-based ARV Drug Combinations for Synergistic Inhibition of Cell-free and Cell-Cell HIV Transmission. Jiang, Y., S. Cao, D.K. Bright, A.M. Bever, A.K. Blakney, I.T. Suydam, and K.A. Woodrow. Molecular Pharmaceutics, 2015. 12(12): p. 4363-4374. PMID[26529558].

[PubMed]. HIV_12_2015.


7. A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-dependent Mechanism. Madu, I.G., S. Li, B. Li, H. Li, T. Chang, Y.J. Li, R. Vega, J. Rossi, J.K. Yee, J. Zaia, and Y. Chen. Scientific Reports, 2015. 5(17808): 8pp. PMID[26643614]. PMCID[PMC4672295].

[PubMed]. HIV_12_2015.


8. The Nucleoside Analog BMS-986001 Shows Greater in Vitro Activity against HIV-2 than against HIV-1. Smith, R.A., D.N. Raugi, V.H. Wu, S.S. Leong, K.M. Parker, M.K. Oakes, P.S. Sow, S. Ba, M. Seydi, and G.S. Gottlieb. Antimicrobial Agents and Chemotherapy, 2015. 59(12): p. 7437-7446. PMID[26392486]. PMCID[PMC4649195].

[PubMed]. HIV_12_2015.


9. A Resveratrol Analog Termed 3,3',4,4',5,5'-Hexahydroxy-trans-stilbene is a Potent HIV-1 Inhibitor. Han, Y.S., P.K. Quashie, T. Mesplede, H. Xu, Y. Quan, W. Jaeger, T. Szekeres, and M.A. Wainberg. Journal of Medical Virology, 2015. 87(12): p. 2054-2060. PMID[25989218].

[PubMed]. HIV_12_2015.


10. SJP-L-5, a Novel Small-molecule Compound, Inhibits HIV-1 Infection by Blocking Viral DNA Nuclear Entry. Bai, R., X.J. Zhang, Y.L. Li, J.P. Liu, H.B. Zhang, W.L. Xiao, J.X. Pu, H.D. Sun, Y.T. Zheng, and L.X. Liu. BMC Microbiology, 2015. 15(274): 13pp. PMID[26630969]. PMCID[PMC4667461].

[PubMed]. HIV_12_2015.


11. A Small Molecule Compound IMB-LA Inhibits HIV-1 Infection by Preventing Viral Vpu from Antagonizing the Host Restriction Factor BST-2. Mi, Z., J. Ding, Q. Zhang, J. Zhao, L. Ma, H. Yu, Z. Liu, G. Shan, X. Li, J. Zhou, T. Wei, L. Zhang, F. Guo, C. Liang, and S. Cen. Scientific Reports, 2015. 5(18499): 13pp. PMID[26669976]. PMCID[PMC4680884].

[PubMed]. HIV_12_2015.


12. Synthesis of a Vpr-binding Derivative for Use as a Novel HIV-1 Inhibitor. Hagiwara, K., H. Ishii, T. Murakami, S.N. Takeshima, N. Chutiwitoonchai, E.N. Kodama, K. Kawaji, Y. Kondoh, K. Honda, H. Osada, Y. Tsunetsugu-Yokota, M. Suzuki, and Y. Aida. Plos One, 2015. 10(12): p. e0145573. PMID[26701275]. PMCID[PMC4689350].

[PubMed]. HIV_12_2015.


13. Synthesis, Antiviral Activity and Resistance of a Novel Small Molecule HIV-1 Entry Inhibitor. Curreli, F., K. Haque, L. Xie, Q. Qiu, J. Xu, W. Yong, X. Tong, and A.K. Debnath. Bioorganic & Medicinal Chemistry, 2015. 23(24): p. 7618-7628. PMID[26602829]. PMCID[PMC4684972].

[PubMed]. HIV_12_2015.


14. Synthesis, Binding and Antiviral Properties of Potent Core-extended Naphthalene diimides Targeting the HIV-1 Long Terminal Repeat Promoter G-quadruplexes. Perrone, R., F. Doria, E. Butovskaya, I. Frasson, S. Botti, M. Scalabrin, S. Lago, V. Grande, M. Nadai, M. Freccero, and S.N. Richter. Journal of Medicinal Chemistry, 2015. 58(24): p. 9639-9652. PMID[26599611].

[PubMed]. HIV_12_2015.

ISI Web of Knowledge Citations

15. Effective Inhibition of HIV-1 Production by Short Hairpin RNAs and Small Interfering RNAs Targeting a Highly Conserved Site in HIV-1 Gag RNA is Optimized by Evaluating Alternative Length Formats. Scarborough, R.J., K.L. Adams, A. Daher, and A. Gatignol. Antimicrobial Agents and Chemotherapy, 2015. 59(9): p. 5297-5305. PMID[26077260]. PMCID[PMC4538472].

[WOS]. HIV_12_2015.


16. Fluorinated Betulinic acid Derivatives and Evaluation of their anti-HIV Activity. Li, J.Z., M. Goto, X.M. Yang, S.L. Morris-Natschke, L. Huang, C.H. Chen, and K.H. Lee. Bioorganic & Medicinal Chemistry Letters, 2016. 26(1): p. 68-71. PMID[26598461].

[WOS]. HIV_12_2015.


17. Henrin A: A New anti-HIV Ent-Kaurane Diterpene from Pteris henryi. Li, W.F., J. Wang, J.J. Zhang, X. Song, C.F. Ku, J. Zou, J.X. Li, L.J. Rong, L.T. Pan, and H.J. Zhang. International Journal of Molecular Sciences, 2015. 16(11): p. 27978-27987. PMID[26610490]. PMCID[PMC4661929].

[WOS]. HIV_12_2015.


18. Inhibitors of HIV-1 Attachment: The Discovery and Structure-activity Relationships of Tetrahydroisoquinolines as Replacements for the Piperazine Benzamide in the 3-Glyoxylyl 6-azaindole Pharmacophore. Swidorski, J.J., Z. Liu, Z.W. Yin, T. Wang, D.J. Carini, S. Rahematpura, M. Zheng, K. Johnson, S. Zhang, P.F. Lin, D.D. Parker, W.Y. Li, N.A. Meanwell, L.G. Hamann, and A. Regueiro-Ren. Bioorganic & Medicinal Chemistry Letters, 2016. 26(1): p. 160-167. PMID[26584882].

[WOS]. HIV_12_2015.


19. Synthesis of the Biotinylated anti-HIV Compound BMMP and the Target Identification Study. Kamo, M., H. Tateishi, R. Koga, Y. Okamoto, M. Otsuka, and M. Fujita. Bioorganic & Medicinal Chemistry Letters, 2016. 26(1): p. 43-45. PMID[26615887].

[WOS]. HIV_12_2015.


20. Synthetic, Structural Mimetics of the beta-Hairpin Flap of HIV-1 Protease Inhibit Enzyme Function. Chauhan, J., S.E. Chen, K.J. Fenstermacher, A. Naser-Tavakolian, T. Reingewertz, R. Salmo, C. Lee, E. Williams, M. Raje, E. Sundberg, J.J. DeStefano, E. Freire, and S. Fletcher. Bioorganic & Medicinal Chemistry, 2015. 23(21): p. 7095-7109. PMID[26474665]. PMCID[PMC4661106].

[WOS]. HIV_12_2015.


21. Tryptophan Dendrimers that Inhibit HIV Replication, Prevent Virus Entry and Bind to the HIV Envelope Glycoproteins gp120 and gp41. Rivero-Buceta, E., E.G. Doyaguez, I. Colomer, E. Quesada, L. Mathys, S. Noppen, S. Liekens, M.J. Camarasa, M.J. Perez-Perez, J. Balzarini, and A. San-Felix. European Journal of Medicinal Chemistry, 2015. 106: p. 34-43. PMID[26513643].

[WOS]. HIV_12_2015.


22. Unciaphenol, an Oxygenated Analogue of the Bergman Cyclization Product of Uncialamycin Exhibits anti-HIV Activity. Williams, D.E., H. Bottriell, J. Davies, I. Tietjen, M.A. Brockman, and R.J. Andersen. Organic Letters, 2015. 17(21): p. 5304-5307. PMID[26465962].

[WOS]. HIV_12_2015.

Patent Citations

23. Preparation of Quinoline Derivatives Useful in Treatment of HIV Infection. Babaoglu, K., R. McFadden, and M.L. Mitchell. Patent. 2015. 2015-US31640 2015179448: 150pp.

[Patent]. HIV_12_2015.


24. Composition Containing used Anthostema senegalense Like Drug against the AIDS [Machine Translation]. Balde, A.M. Patent. 2015. 2014-55226 3021871.

[Patent]. HIV_12_2015.


25. Preparation of Benzylpyrazolylpiperidine Compounds as Chemokine CXCR4 and CCR5 Receptor Modulators. Cox, B.D., L.J. Wilson, A. Prosser, D.C. Liotta, and J.P. Snyder. Patent. 2015. 2015-US30923 2015175855: 98pp.

[Patent]. HIV_12_2015.


26. Preparation and Application of 3,4-Disubstituted-6-phenethylpyridone-type HIV-1 Reverse Transcriptase Inhibitor. Liu, J., X. Wang, Y. Cao, Z. Zhang, Y. Guo, and C. Tian. Patent. 2015. 2014-10154784 105017139: 24pp.

[Patent]. HIV_12_2015.


27. Preparation of Diaminopiperidine Derivatives and Analogs for Use as anti-HIV Agents. Micouin, L., A. Blond, V. Calvez, A.-G. Marcellin, C. Soulie, and E. Corrot. Patent. 2015. 2015-EP62046 2015181387: 74pp.

[Patent]. HIV_12_2015.


28. Preparation of Peptide Analogs as Inhibitor of Apoptosis Protein (IAP) Antagonists in HIV Therapy. Pache, L., S.K. Chanda, M.D. Vamos, N.D.P. Cosford, P. Teriete, J. Marlett, A. Diaz, and J.A.T. Young. Patent. 2015. 2015-US34281 2015187998: 245pp.

[Patent]. HIV_12_2015.


29. Dimerization-resistant CXCl121 Variants and Their Therapeutic Uses. Volkman, B., J. Ziarek, C. Veldkamp, and F. Peterson. Patent. 2015. 2015-14736535 20150361152: 69pp.

[Patent]. HIV_12_2015.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2024